PL328096A1 - Expression of external membrane (mb3) protein of neisseria meningitidis of b group in yeasts and vaccines - Google Patents
Expression of external membrane (mb3) protein of neisseria meningitidis of b group in yeasts and vaccinesInfo
- Publication number
- PL328096A1 PL328096A1 PL97328096A PL32809697A PL328096A1 PL 328096 A1 PL328096 A1 PL 328096A1 PL 97328096 A PL97328096 A PL 97328096A PL 32809697 A PL32809697 A PL 32809697A PL 328096 A1 PL328096 A1 PL 328096A1
- Authority
- PL
- Poland
- Prior art keywords
- yeasts
- vaccines
- protein
- expression
- group
- Prior art date
Links
- 241000588650 Neisseria meningitidis Species 0.000 title 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 title 1
- 239000012528 membrane Substances 0.000 title 1
- 102000004169 proteins and genes Human genes 0.000 title 1
- 108090000623 proteins and genes Proteins 0.000 title 1
- 229960005486 vaccine Drugs 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/22—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Neisseriaceae (F)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
- A61K47/646—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent the entire peptide or protein drug conjugate elicits an immune response, e.g. conjugate vaccines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/14—Fungi; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Microbiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Biophysics (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Virology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Plant Pathology (AREA)
- Gastroenterology & Hepatology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Botany (AREA)
- Physics & Mathematics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US1097296P | 1996-02-01 | 1996-02-01 | |
| US2044096P | 1996-06-13 | 1996-06-13 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL328096A1 true PL328096A1 (en) | 1999-01-04 |
Family
ID=26681820
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL97328096A PL328096A1 (en) | 1996-02-01 | 1997-01-31 | Expression of external membrane (mb3) protein of neisseria meningitidis of b group in yeasts and vaccines |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP0877816A1 (no) |
| JP (1) | JP2001508758A (no) |
| KR (1) | KR19990082265A (no) |
| AU (1) | AU2115897A (no) |
| HU (1) | HUP9901039A2 (no) |
| IL (1) | IL125420A0 (no) |
| NO (1) | NO983474L (no) |
| PL (1) | PL328096A1 (no) |
| WO (1) | WO1997028273A1 (no) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR9811475A (pt) | 1997-07-17 | 2000-08-15 | North American Vaccine Inc | Conjugados imunogênicos compreendendo uma porina meningocóccica de grupo b e um polissacarìdeo de h. influenzae |
| DK1093517T3 (da) | 1998-05-01 | 2008-06-23 | Novartis Vaccines & Diagnostic | Neisseria-meningitidis-antigener og præparater |
| DE69941406D1 (de) * | 1998-07-06 | 2009-10-22 | Tosoh Corp | IL-6 Rezeptor IL-6-gekoppeltes Fusionsprotein |
| JP4524816B2 (ja) * | 1998-07-06 | 2010-08-18 | 東ソー株式会社 | Ｉｌ−６レセプター・ｉｌ−６直結融合蛋白質 |
| GB9818004D0 (en) * | 1998-08-18 | 1998-10-14 | Smithkline Beecham Biolog | Novel compounds |
| MXPA01010924A (es) | 1999-04-30 | 2002-05-06 | Chiron Spa | Antigenos de neisseria conservados. |
| HUP0201220A3 (en) | 1999-05-13 | 2004-07-28 | Wyeth Holdings Corp Madison | Adjuvant combination formulations |
| AU783894B2 (en) | 1999-05-19 | 2005-12-22 | Novartis Vaccines And Diagnostics S.R.L. | Combination neisserial compositions |
| EP1069133A1 (en) * | 1999-07-13 | 2001-01-17 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | Neisseria meningitidis compounds and anti-infection applications thereof |
| GB9928196D0 (en) * | 1999-11-29 | 2000-01-26 | Chiron Spa | Combinations of B, C and other antigens |
| AU1875301A (en) | 1999-11-29 | 2001-06-04 | Chiron S.P.A. | 85kda neisserial antigen |
| ES2588917T3 (es) | 2000-01-17 | 2016-11-07 | Glaxosmithkline Biologicals Sa | Vacuna de VME suplementada contra meningococo |
| EP1947187B9 (en) * | 2000-02-28 | 2011-09-21 | Novartis Vaccines and Diagnostics S.r.l. | Hybrid expression of neisserial proteins |
| GB0115176D0 (en) | 2001-06-20 | 2001-08-15 | Chiron Spa | Capular polysaccharide solubilisation and combination vaccines |
| SI1549338T1 (sl) | 2002-10-11 | 2011-04-29 | Novartis Vaccines & Diagnostic | Polipeptidna cepiva za ĺ iroko zaĺ äśito pred hipervirulentnimi miningokoknimi rodovi |
| PT1587537E (pt) | 2003-01-30 | 2012-05-30 | Novartis Ag | Vacinas injetáveis contra múltiplos serogrupos meningocócicos |
| JP2006262846A (ja) * | 2005-03-25 | 2006-10-05 | Niigata Bio Research Park Kk | 酵母による２−デオキシ−シロ−イノソースの合成および精製する方法並びに得られた２−デオキシ−シロ−イノソース |
| KR100919704B1 (ko) * | 2007-09-12 | 2009-10-06 | 한국생명공학연구원 | 효모에서 재조합단백질을 고효율로 분비발현시키는 방법 |
| JP2011116658A (ja) * | 2008-03-13 | 2011-06-16 | Chemo-Sero-Therapeutic Research Inst | 豚萎縮性鼻炎用薬剤の製造方法 |
| WO2015073801A1 (en) | 2013-11-14 | 2015-05-21 | Duke University | Tetanus toxoid and ccl3 improve dc vaccines |
| CN106146679B (zh) * | 2015-04-23 | 2019-02-01 | 中国医学科学院医学生物学研究所 | 一种纯化细菌荚膜多糖的方法 |
| HUE058104T2 (hu) | 2015-05-11 | 2022-07-28 | Impossible Foods Inc | Expressziós konstrukciók és eljárások a metilotróf élesztõ genetikai módosítására |
| CA3010288A1 (en) * | 2015-12-30 | 2017-07-06 | Dsm Ip Assets B.V. | Partial enzymatic hydrolysis of triacylglycerols |
| JP2022529021A (ja) | 2019-04-17 | 2022-06-16 | インポッシブル フーズ インコーポレイテッド | タンパク質作製の材料および方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4356170A (en) * | 1981-05-27 | 1982-10-26 | Canadian Patents & Development Ltd. | Immunogenic polysaccharide-protein conjugates |
| NZ239643A (en) * | 1990-09-17 | 1996-05-28 | North American Vaccine Inc | Vaccine containing bacterial polysaccharide protein conjugate and adjuvant (c-nd-che-a-co-b-r) with a long chain alkyl group. |
| US5268273A (en) * | 1990-12-14 | 1993-12-07 | Phillips Petroleum Company | Pichia pastoris acid phosphatase gene, gene regions, signal sequence and expression vectors comprising same |
| US5439808A (en) * | 1993-07-23 | 1995-08-08 | North American Vaccine, Inc. | Method for the high level expression, purification and refolding of the outer membrane group B porin proteins from Neisseria meningitidis |
-
1997
- 1997-01-31 KR KR1019980705994A patent/KR19990082265A/ko not_active Application Discontinuation
- 1997-01-31 IL IL12542097A patent/IL125420A0/xx unknown
- 1997-01-31 EP EP97906470A patent/EP0877816A1/en not_active Ceased
- 1997-01-31 HU HU9901039A patent/HUP9901039A2/hu unknown
- 1997-01-31 PL PL97328096A patent/PL328096A1/xx unknown
- 1997-01-31 WO PCT/US1997/001687 patent/WO1997028273A1/en not_active Application Discontinuation
- 1997-01-31 JP JP52788197A patent/JP2001508758A/ja active Pending
- 1997-01-31 AU AU21158/97A patent/AU2115897A/en not_active Abandoned
-
1998
- 1998-07-28 NO NO983474A patent/NO983474L/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| HUP9901039A2 (hu) | 1999-07-28 |
| AU2115897A (en) | 1997-08-22 |
| IL125420A0 (en) | 1999-03-12 |
| KR19990082265A (ko) | 1999-11-25 |
| NO983474L (no) | 1998-09-30 |
| NO983474D0 (no) | 1998-07-28 |
| JP2001508758A (ja) | 2001-07-03 |
| WO1997028273A1 (en) | 1997-08-07 |
| EP0877816A1 (en) | 1998-11-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL328096A1 (en) | Expression of external membrane (mb3) protein of neisseria meningitidis of b group in yeasts and vaccines | |
| AU657487B2 (en) | Nucleotide sequence coding for an outer membrane protein from neisseria meningitidis and use of said protein in vaccine preparations | |
| PL312712A1 (en) | High level expression, purification and repeated creasing of group b(porynowe?) proteins of outer membrane of neisseria meningitidis | |
| DK0486290T3 (da) | Fremgangsmåde og præparat til forøgelse af akkumulering af squalen og specifikke steroler i gær | |
| GB2314013B (en) | Integrated dental chair and post-mounted delivery system | |
| EP0895535A4 (en) | REPLICATION OF INFLUENZA VIRUS IN MAMMALIAN CELL CULTURE AND VACCINE PRODUCTION | |
| HUP9800901A3 (en) | Process, medium and cell culture system for the preparation of recombinant factor viii in a protein free medium | |
| PL322589A1 (en) | Radiotracer-labelled peptides for use in diagnostics and therapy | |
| IL114160A0 (en) | Polypeptides expressed in yeasts and their preparation | |
| NO992779D0 (no) | OB-fusjonsproteinpreparater og fremgangsmÕte for fremstilling av slike | |
| IL115261A0 (en) | Three-dimensional human cell cultures on cardiac valve frameworks and their uses | |
| AU1420995A (en) | Improvements in and relating to seat arrangements providing adjustable support | |
| IL93957A0 (en) | Bordetella outer membrane proteins,their use in vaccines and their expression | |
| IL118119A0 (en) | Azacycloalkane derivatives their preparation and their application in therapy | |
| GB2275029B (en) | Improvements in and relating to wheelchairs | |
| AU3636195A (en) | Support post for use in dental implant system | |
| CZ202497DA3 (en) | Glycoproteins rich in hydroxy proline and preparations containing thereof | |
| EP0814832A4 (en) | ISOLEFORMS OF THE INTERLEUKIN-1BETA CONVERSION ENZYME AND METHODS OF USE THEREOF | |
| EP0766741A4 (en) | GM-CSF CONTAINED FUSION PROTEINS AND ANTIGENS AND THEIR EXPRESSION IN YEAST | |
| EE9800188A (et) | N-atsetüül-(L)-4-tsüanofenüülalaniini Ac-(L)-Phe- (4-CN)-OH ja N-atsetüül- (L)-p-amidinofenüülalaniintsükloheksüülglütsiin-ß- (3-N-metüülpüridiinium)alaniini Ac-(L)-pAph-Chg-PalMe(3)-NH2 valmistamismeetod | |
| GB9523497D0 (en) | Cell membrane protein and application thereof | |
| AU3956195A (en) | Methods for producing enhanced antigenic enteric bacteria and vaccines comprising same | |
| AU5735299A (en) | Basb024 outer membrane protein of neisseria meningitidis | |
| IL98839A0 (en) | Vaccines comprising protein of the outer membrane of neisseria meningitidis | |
| AU5978596A (en) | Liposomes containing human immunodeficiency virus glycoprote in and methods for use thereof |